Logo image of AMN

AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis

USA - NYSE:AMN - US0017441017 - Common Stock

20.51 USD
+0.65 (+3.27%)
Last: 10/21/2025, 8:04:00 PM
20.51 USD
0 (0%)
After Hours: 10/21/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, AMN scores 4 out of 10 in our fundamental rating. AMN was compared to 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of AMN while its profitability can be described as average. AMN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AMN had positive earnings in the past year.
In the past year AMN had a positive cash flow from operations.
AMN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years AMN had a positive operating cash flow.
AMN Yearly Net Income VS EBIT VS OCF VS FCFAMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

The Return On Assets of AMN (-13.46%) is worse than 79.21% of its industry peers.
AMN has a Return On Equity of -49.02%. This is in the lower half of the industry: AMN underperforms 73.27% of its industry peers.
The Return On Invested Capital of AMN (2.66%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for AMN is above the industry average of 9.33%.
The last Return On Invested Capital (2.66%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
Industry RankSector Rank
ROA -13.46%
ROE -49.02%
ROIC 2.66%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
AMN Yearly ROA, ROE, ROICAMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

AMN's Operating Margin of 2.12% is in line compared to the rest of the industry. AMN outperforms 50.49% of its industry peers.
AMN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 29.84%, AMN is in line with its industry, outperforming 56.44% of the companies in the same industry.
In the last couple of years the Gross Margin of AMN has declined.
Industry RankSector Rank
OM 2.12%
PM (TTM) N/A
GM 29.84%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
AMN Yearly Profit, Operating, Gross MarginsAMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMN is creating some value.
The number of shares outstanding for AMN has been increased compared to 1 year ago.
Compared to 5 years ago, AMN has less shares outstanding
The debt/assets ratio for AMN has been reduced compared to a year ago.
AMN Yearly Shares OutstandingAMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AMN Yearly Total Debt VS Total AssetsAMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.38 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
AMN has a Altman-Z score (2.38) which is in line with its industry peers.
The Debt to FCF ratio of AMN is 3.59, which is a good value as it means it would take AMN, 3.59 years of fcf income to pay off all of its debts.
AMN's Debt to FCF ratio of 3.59 is fine compared to the rest of the industry. AMN outperforms 74.26% of its industry peers.
AMN has a Debt/Equity ratio of 1.51. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of AMN (1.51) is worse than 69.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF 3.59
Altman-Z 2.38
ROIC/WACC0.35
WACC7.53%
AMN Yearly LT Debt VS Equity VS FCFAMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

AMN has a Current Ratio of 1.00. This is a bad value and indicates that AMN is not financially healthy enough and could expect problems in meeting its short term obligations.
AMN has a worse Current ratio (1.00) than 72.28% of its industry peers.
A Quick Ratio of 1.00 indicates that AMN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.00, AMN is doing worse than 69.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
AMN Yearly Current Assets VS Current LiabilitesAMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.73%.
The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
Looking at the last year, AMN shows a very negative growth in Revenue. The Revenue has decreased by -14.33% in the last year.
AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-59.73%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-69.39%
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-11.14%

3.2 Future

The Earnings Per Share is expected to grow by 22.82% on average over the next years. This is a very strong growth
AMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.40% yearly.
EPS Next Y-65.14%
EPS Next 2Y-42.68%
EPS Next 3Y-22.59%
EPS Next 5Y22.82%
Revenue Next Year-12.08%
Revenue Next 2Y-7.19%
Revenue Next 3Y-3.17%
Revenue Next 5Y4.4%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMN Yearly Revenue VS EstimatesAMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
AMN Yearly EPS VS EstimatesAMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.72, the valuation of AMN can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 92.08% of the companies listed in the same industry.
AMN is valuated cheaply when we compare the Price/Earnings ratio to 27.77, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.86, which indicates a rather expensive current valuation of AMN.
65.35% of the companies in the same industry are more expensive than AMN, based on the Price/Forward Earnings ratio.
AMN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.72
Fwd PE 18.86
AMN Price Earnings VS Forward Price EarningsAMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

82.18% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AMN is valued cheaper than 99.01% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.08
EV/EBITDA 7.45
AMN Per share dataAMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as AMN's earnings are expected to decrease with -22.59% in the coming years.
PEG (NY)N/A
PEG (5Y)12.08
EPS Next 2Y-42.68%
EPS Next 3Y-22.59%

0

5. Dividend

5.1 Amount

AMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMN HEALTHCARE SERVICES INC

NYSE:AMN (10/21/2025, 8:04:00 PM)

After market: 20.51 0 (0%)

20.51

+0.65 (+3.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners105.31%
Inst Owner Change0.1%
Ins Owners0.42%
Ins Owner Change0.71%
Market Cap785.94M
Analysts69.23
Price Target20.4 (-0.54%)
Short Float %8.71%
Short Ratio3.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)84.83%
Min EPS beat(2)53.64%
Max EPS beat(2)116.02%
EPS beat(4)4
Avg EPS beat(4)56.81%
Min EPS beat(4)5.34%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)34.9%
EPS beat(12)12
Avg EPS beat(12)26.31%
EPS beat(16)16
Avg EPS beat(16)23.47%
Revenue beat(2)1
Avg Revenue beat(2)0.91%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.88%
Revenue beat(4)3
Avg Revenue beat(4)1.99%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)4
Avg Revenue beat(8)0.84%
Revenue beat(12)7
Avg Revenue beat(12)1.1%
Revenue beat(16)11
Avg Revenue beat(16)1.97%
PT rev (1m)0%
PT rev (3m)-24.63%
EPS NQ rev (1m)-3.03%
EPS NQ rev (3m)-13.98%
EPS NY rev (1m)-1.93%
EPS NY rev (3m)1.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.33%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-2.28%
Valuation
Industry RankSector Rank
PE 9.72
Fwd PE 18.86
P/S 0.28
P/FCF 3.08
P/OCF 2.53
P/B 1.29
P/tB N/A
EV/EBITDA 7.45
EPS(TTM)2.11
EY10.29%
EPS(NY)1.09
Fwd EY5.3%
FCF(TTM)6.67
FCFY32.51%
OCF(TTM)8.11
OCFY39.54%
SpS72.28
BVpS15.86
TBVpS-12.28
PEG (NY)N/A
PEG (5Y)12.08
Profitability
Industry RankSector Rank
ROA -13.46%
ROE -49.02%
ROCE 3.58%
ROIC 2.66%
ROICexc 2.73%
ROICexgc 8.39%
OM 2.12%
PM (TTM) N/A
GM 29.84%
FCFM 9.22%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexcg growth 3Y-38.44%
ROICexcg growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF 3.59
Debt/EBITDA 4.11
Cap/Depr 33.64%
Cap/Sales 1.99%
Interest Coverage 1.13
Cash Conversion 139.35%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 2.38
F-Score4
WACC7.53%
ROIC/WACC0.35
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.73%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-69.39%
EPS Next Y-65.14%
EPS Next 2Y-42.68%
EPS Next 3Y-22.59%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-11.14%
Revenue Next Year-12.08%
Revenue Next 2Y-7.19%
Revenue Next 3Y-3.17%
Revenue Next 5Y4.4%
EBIT growth 1Y-70.44%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year92.53%
EBIT Next 3Y25.77%
EBIT Next 5YN/A
FCF growth 1Y-32.27%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-33.9%
OCF growth 3Y1.61%
OCF growth 5Y7.34%